mBio · 2021 · 265 citations · 92 references
Life SciencesInfectious DiseasesMicrobiologyGastroenterologyMedical MicrobiologyMicrobial PathogenesisGastrointestinal InfectionsGastrointestinal InflammationGastrointestinal PathologyGastrointestinal PathophysiologyGut MicrobiotaMucosal PathogenesisGastrointestinal Barrier DysfunctionGut Microbiota EffectsIntestinal Mucosal PathogenesisMicrobial Ecology Of The GutMucosal Defense MechanismsMucosal MicrobiotaMucosal Physiology
Several studies have identified an increased abundance of Fusobacterium in the intestinal tracts of patients with colon cancer, liver cirrhosis, primary sclerosing cholangitis, gastroesophageal reflux disease, HIV infection, and alcoholism. However, the direct mechanism(s) of action of Fusobacterium on pathophysiological within the gastrointestinal tract is unclear.
92
Daniel N. Frank, Allison L. St. Amand, Robert A. Feldman et al. · Proceedings of the National Academy of Sciences · 2007 · 4.6K citations · Full text
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Dirk Gevers, Subra Kugathasan, Lee A. Denson et al. · Cell Host & Microbe · 2014 · 3.3K citations · Full text